FIELD: medicine.
SUBSTANCE: taken venous blood is separated into two samples. The first sample is stabilised with a solution of sodium citrate, the second one - with ethylene diamine tetraacetate. The first sample of whole blood is added with adenosine diphosphate as an aggregation inducer and tested for a peak amplitude of thrombocyte aggregation and a peak amplitude of adenosine triphosphate release profile by impedance method. The second sample is used to measure a fraction of thrombocytes and a fraction of blood corpuscles. It is followed by calculating a thrombocyte aggregation potential index by formula
EFFECT: improving the objective estimation of the clinical effectiveness of the antiaggregant therapy in the patients with acute coronary syndrome, and providing an opportunity for predicting the clinical course of the disease.
1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF INDIVIDUAL PROGNOSIS OF CLINICAL EFFECTIVENESS OF DUAL ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME | 2016 |
|
RU2639772C1 |
METHOD FOR THROMBOCYTE AGGREGATION ACTIVITY DETERMINATION FOR PATIENTS WITH ACUTE CORONARY SYNDROME | 2016 |
|
RU2619858C1 |
METHOD OF DETERMINING PLATELET RESISTANCE TO ACETYLSALICYLIC ACID | 2013 |
|
RU2538219C2 |
METHOD OF ASSESSING RISK OF RECURRENT THROMBOTIC EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROME | 2010 |
|
RU2419800C1 |
METHOD FOR ADVERSE CARDIAC EVENTS RISK ASSESSMENT AFTER PERCUTANEOUS CORONARY INTERVENTION | 2015 |
|
RU2618448C1 |
METHOD FOR PREDICTION OF ANTIPLATELET THERAPY EFFICIENCY REDUCTION RISK | 2016 |
|
RU2623051C1 |
METHOD OF EARLY PREDICTION OF RISK OF DEVELOPING VASCULAR INVOLVEMENTS IN ONSET OF ENDOCRINOPATHIES | 2010 |
|
RU2426123C1 |
METHOD OF PREDICTION OF ASPIRIN RESISTANCE | 2015 |
|
RU2602664C1 |
METHOD OF EVALUATING THE EFFECTIVENESS OF NON-AGGREGATE PREPARATIONS AFFECTING THE METABOLISM OF ARACHIDONIC ACID BY INHIBITION OF CYCLOOXYGENASE-1 BOTH INDIVIDUALLY AND JOINTLY WITH ADP P2Y RECEPTOR ANTAGONIST ON PLATELET MEMBRANES OF THE BLOOD TO THE PATIENT RECEIVING NON-AGGREGATE PREPARATIONS | 2010 |
|
RU2442167C1 |
METHOD OF DETERMINING THROMBOCYTE SENSITIVITY TO ACETYLSALICYLIC ACID | 2018 |
|
RU2699569C1 |
Authors
Dates
2013-06-27—Published
2011-11-23—Filed